SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-17-002067
Filing Date
2017-02-09
Accepted
2017-02-09 21:03:29
Documents
1
Period of Report
2017-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 2017 rdgdoc.html 4  
1 FORM 4 2017 rdgdoc.xml 4 4051
  Complete submission text file 0001437749-17-002067.txt   5409
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Issuer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACELRX PHARMACEUTICALS INC. 575 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address
Hamel Lawrence G (Reporting) CIK: 0001511368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35068 | Film No.: 17589293